Chymotrypsin C in pancreatitis

胰凝乳蛋白酶 C 在胰腺炎中的作用

基本信息

批准号：
8785119
负责人：
Miklos Sahin-Toth
金额：
$ 35.6万
依托单位：
BOSTON UNIVERSITY MEDICAL CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-04-01 至 2018-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8785119
关键词：
Acinar Cell Advanced Development Applications Grants Back Biochemical Biochemical Pathway Biological Cells Comparative Study Data Defect Disease Disease model Enzymes Funding Genes Genetic Genetic Risk Grant Health Hereditary Disease Human Human Genetics In Vitro Inbred Strains Mice Inbreeding Inflammatory Injury Knock-out Mediating Molecular Mus Mutation Pancreas Pancreatitis Pathway interactions Predisposition Protein Isoforms Proteins Recurrence Research Risk Risk Factors Specificity Testing Transgenic Mice Transgenic Organisms Trypsin Trypsinogen Work acute pancreatitis cell injury chronic pancreatitis chymotrypsin chymotrypsin C clinically relevant congenic endoplasmic reticulum stress genetic association genetic risk factor in vivo insight mouse model mutant novel diagnostics novel therapeutic intervention premature programs response

项目摘要

DESCRIPTION (provided by applicant): The main objective of this grant is to determine the mechanisms by which chymotrypsin C (CTRC) mutations act as risk factors for chronic pancreatitis in humans. The project forms a part of our broad, long-term research program to understand the molecular mechanisms of genetic risk factors associated with human pancreatitis. These studies so far combined biochemical and cell biological approaches with data obtained from human genetic association studies to formulate a molecular disease model for recurrent acute and chronic pancreatitis. Our current working hypothesis is that genetic risk in pancreatitis is mediated via two independent pathological pathways, which can result in acinar cell damage. In the trypsin-dependent pathological pathway intra-pancreatic autoactivation of trypsinogen to active trypsin is responsible for cell injury; whereas in the misfolding-dependent pathological pathway retention of misfolded mutant proteins can damage acinar cells through induction of endoplasmic reticulum stress. In the previous funding period we established that CTRC mutations are highly significant risk factors for chronic pancreatitis and these mutations exert their effect primarily through the trypsin-dependent pathway, while a subset of CTRC mutants also engages the misfolding-dependent pathway. In the next funding period our aim is to validate our conclusions in vivo and create and characterize mouse models that will test whether genetic deletion of mouse Ctrc increases intra-pancreatic trypsinogen activation and pancreatitis responses; and whether transgenic expression of a misfolding human CTRC mutant in the mouse pancreas causes endoplasmic reticulum stress, acinar cell damage and increased susceptibility to pancreatitis.

描述（由申请人提供）：本次资助的主要目的是确定胰凝乳蛋白酶 C (CTRC) 突变作为人类慢性胰腺炎危险因素的机制。该项目是我们广泛、长期研究计划的一部分，旨在了解与人类胰腺炎相关的遗传风险因素的分子机制。迄今为止，这些研究将生化和细胞生物学方法与人类遗传关联研究获得的数据相结合，制定了复发性急性和慢性胰腺炎的分子疾病模型。我们目前的工作假设是，胰腺炎的遗传风险是通过两个独立的病理途径介导的，这可能导致腺泡细胞损伤。在胰蛋白酶依赖性病理通路中，胰蛋白酶原在胰腺内自动激活为活性胰蛋白酶，从而导致细胞损伤；而在错误折叠依赖性病理通路中，错误折叠突变蛋白的保留可以通过诱导内质网应激来损伤腺泡细胞。在之前的资助期间，我们确定 CTRC 突变是慢性胰腺炎的高度重要危险因素，这些突变主要通过胰蛋白酶依赖性途径发挥作用，而 CTRC 突变体的子集也参与错误折叠依赖性途径。在下一个资助期间，我们的目标是在体内验证我们的结论，并创建和表征小鼠模型，以测试小鼠 Ctrc 的基因删除是否会增加胰腺内胰蛋白酶原激活和胰腺炎反应；以及错误折叠的人类 CTRC 突变体在小鼠胰腺中的转基因表达是否会导致内质网应激、腺泡细胞损伤和胰腺炎易感性增加。